Abstract: An object of the present invention is to provide a low molecular weight compound having a prophylactic or therapeutic action on cancer. A compound of the following formula (1), a compound of the following formula (2), or the like can be administered by a method such as oral administration to prevent or treat cancers such as colorectal cancer.

Abstract: A projector in an installation information acquisition method is installed in a real space, has a changeable projection direction, and projects a projection image based on a virtual image. The virtual image is an image in a case where an image arranged at a display position in a virtual space is viewed from a virtual installation position. The method includes first acquisition processing for acquiring positional information of three or more first adjustment points in the virtual space, projection processing for projecting, by the projector, an index image onto the real space, second acquisition processing for acquiring angle information of the projection direction with respect to a reference direction in a state where the index image matches three or more second adjustment points respectively corresponding to the three or more first adjustment points, and third acquisition processing for acquiring installation information based on the positional information and the angle information.

Abstract: A changed part identification unit (27) compares original data that is design data (41) before being changed with changed data is the design data (41) after being changed in terms of each piece of design information that is a constituent of each of the original data and the changed data. The changed part identification unit (27) thus identifies a changed part in a control program (51) generated from the original data. A change reflection unit (28) updates the control program (51) by setting a new program component generated from the changed data for the changed part identified by the changed part identification unit (27).

Abstract: A projector in an installation information acquisition method is installed in a real space, has a changeable projection direction, and projects a projection image based on a virtual image. The virtual image is an image in a case where an image arranged at a display position in a virtual space is viewed from a virtual installation position. The method includes first acquisition processing for acquiring positional information of three or more first adjustment points in the virtual space, projection processing for projecting, by the projector, an index image onto the real space, second acquisition processing for acquiring angle information of the projection direction with respect to a reference direction in a state where the index image matches three or more second adjustment points respectively corresponding to the three or more first adjustment points, and third acquisition processing for acquiring installation information based on the positional information and the angle information.

Abstract: A content generation method generates image content to be projected at a projection position in a real space by a projector. In a first acquisition process, space information regarding a virtual space corresponding to the real space is acquired. In a second acquisition process, display position information regarding a display position corresponding to the projection position in the virtual space is acquired. In a third acquisition process, reference position information regarding a reference position in the virtual space is acquired. In a generation process, an image including an object viewed from the reference position when the object is displayed at the display position in the virtual space is generated as the image content, based on the space information, the reference position information, and the display position information.

Abstract: An object of the present invention is to provide an agent for enhancing fertilization function of a mammal sperm, which comprises a low molecular compound which can be produced relatively easily and inexpensively as an active ingredient, and a method for enhancing fertilization function of a mammal sperm and a method for preparing a mammal fertilized egg, which use a low molecular compound which can be produced relatively easily and inexpensively. An agent comprising one or more compounds selected from the group consisting of compounds of the following formula (I0), formula (II), and formula (III), and physiologically acceptable salts thereof when R3 is OH is used as an agent for enhancing fertilization function of a mammal sperm.

Abstract: It is to provide an agent for anti-aging or cellular rejuvenation, and an agent for preventing or ameliorating symptoms or diseases associated with aging, in which a low-molecular compound that can be produced relatively simply and inexpensively is contained as an active ingredient. Provided are an agent for anti-aging or cellular rejuvenation and a preventive or ameliorative agent for a symptom or disease associated with aging. Such agents contain one or more compounds selected from the group consisting of a compound represented by General Formula (I0), a compound represented by General Formula (II), a compound represented by General Formula (III) and pharmaceutically acceptable salts thereof when R3 is OH.

Abstract: An S(+) form of 4-(2,4-difluorophenyl)-2-(1H-indol-3-yl)-4-oxo-butanoic acid or a physiologically acceptable salt thereof may be useful as an active ingredient of a pharmaceutical composition or a food or drink composition, and the like. An enantiomeric excess of an S(+) form may be at least 97% or more. The compound may be used in treating, improving, or preventing a mitochondrial disease and/or a symptom or a disease associated with aging.

Abstract: A projector in an installation information acquisition method is installed in a real space, has a changeable projection direction, and projects a projection image based on a virtual image. The virtual image is an image in a case where an image arranged at a display position in a virtual space is viewed from a virtual installation position. The method includes first acquisition processing for acquiring positional information of three or more first adjustment points in the virtual space, projection processing for projecting, by the projector, an index image onto the real space, second acquisition processing for acquiring angle information of the projection direction with respect to a reference direction in a state where the index image matches three or more second adjustment points respectively corresponding to the three or more first adjustment points, and third acquisition processing for acquiring installation information based on the positional information and the angle information.

Abstract: A projection direction change device includes a mirror that reflects light emitted from a projection lens unit of a projector, a mirror support part that rotatably supports the mirror around a first axis and a second axis, a first drive part that rotary drives the mirror around the first axis, and a second drive part that rotary drives the mirror around the second axis. An intersecting point of the first and second axes is positioned closer to the projection lens unit than a geometric barycenter of the mirror is.

Abstract: A problem to be solved by the present invention is to provide a uremic toxin reducing agent, a total cholesterol reducing agent and a triglyceride reducing agent. The problem is solved by providing a uremic toxin reducing agent, a total cholesterol reducing agent and a triglyceride reducing agent, wherein each agent comprises Lactobacillus bacteria, Bifidobacterium bacteria or Bacteroides bacteria.

Abstract: A means for substantially improving mitochondrial dysfunction is provided. An aspect of the present invention relates to an agent for improving mitochondrial dysfunction, having a compound represented by the following formula, a stereoisomer or a salt thereof, or a solvate thereof, as an active ingredient. Another aspect of the present invention relates to a medicament or a pharmaceutical composition having the aforementioned compound, a stereoisomer or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof, as an active ingredient, for use in preventing or treating a disease or symptom caused by mitochondrial dysfunction.

Abstract: An object of the present invention is to provide a low molecular weight compound having a prophylactic or therapeutic action on cancer. A compound of the following formula (1), a compound of the following formula (2), or the like can be administered by a method such as oral administration to prevent or treat cancers such as colorectal cancer.

Abstract: An object of the present invention is to provide an agent for enhancing fertilization function of a mammal sperm, which comprises a low molecular compound which can be produced relatively easily and inexpensively as an active ingredient, and a method for enhancing fertilization function of a mammal sperm and a method for preparing a mammal fertilized egg, which use a low molecular compound which can be produced relatively easily and inexpensively. An agent comprising one or more compounds selected from the group consisting of compounds of the following formula (I0), formula (II), and formula (III), and physiologically acceptable salts thereof when R3 is OH is used as an agent for enhancing fertilization function of a mammal sperm.

Abstract: A content generation method generates image content to be projected at a projection position in a real space by a projector. In a first acquisition process, space information regarding a virtual space corresponding to the real space is acquired. In a second acquisition process, display position information regarding a display position corresponding to the projection position in the virtual space is acquired. In a third acquisition process, reference position information regarding a reference position in the virtual space is acquired. In a generation process, an image including an object viewed from the reference position when the object is displayed at the display position in the virtual space is generated as the image content, based on the space information, the reference position information, and the display position information.

Abstract: It is to provide an agent for preventing or improving hearing loss, which comprises a low molecular compound which can be produced relatively easily and inexpensively as an active ingredient. One or more compounds selected from the group consisting of compounds represented by the following formulas (I0), (II), and (III) and a pharmaceutically acceptable salt of the compounds when R3 is OH are used as an agent for preventing or improving hearing loss.

Abstract: A projection direction change device includes a mirror that reflects light emitted from a projection lens unit of a projector, a mirror support part that rotatably supports the mirror around a first axis and a second axis, a first drive part that rotary drives the mirror around the first axis, and a second drive part that rotary drives the mirror around the second axis. An intersecting point of the first and second axes is positioned closer to the projection lens unit than a geometric barycenter of the mirror is.

Abstract: It is an object of the present invention to provide a novel therapeutic agent and method for treating amyotrophic diseases, and more specifically a therapeutic agent and method for treating neurogenic amyotrophic disorders such as amyotrophic lateral sclerosis (ALS) and myogenic amyotrophic disorders such as sarcopenia or disuse muscle atrophy. Provided is a therapeutic agent for amyotrophic diseases that comprises one or more compounds selected from the group consisting of compounds represented by the formula (I), the formula (II) and the formula (III), and pharmaceutically acceptable salts of the compounds when R3 represents OH.

Abstract: An image signal processing device receives image signals from source devices and outputs image signals via a plurality of communication paths. The image signal processing device includes a plurality of compression circuits, a transmission circuit and a path/compression-rate setting circuit. The plurality of compression circuits compress image signals to be transmitted via the plurality of communication paths. The transmission circuit outputs the image signals compressed. The path/compression-rate setting circuit, based on each data amount of the image signals received, determines a communication path for transmitting a part or the whole of each of the image signal, and sets a common compression rate for all of the plurality of compression circuits. The path/compression-rate setting circuit divides an image signal having a relatively large data amount, and assigns a part of the divided image signal to a communication path for transmitting an image signal having a relatively small data amount.

Abstract: A means for substantially improving mitochondrial dysfunction is provided. An aspect of the present invention relates to an agent for improving mitochondrial dysfunction, having a compound represented by the following formula, a stereoisomer or a salt thereof, or a solvate thereof, as an active ingredient. Another aspect of the present invention relates to a medicament or a pharmaceutical composition having the aforementioned compound, a stereoisomer or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof, as an active ingredient, for use in preventing or treating a disease or symptom caused by mitochondrial dysfunction.